News Details
20/08/2026 10:47
Lupin - Arrangements for strategic, technical, manufacturing, or marketing tie up
Lupin Limited has informed the Exchange about VISUfarma B.V., the Netherlands, a wholly owned subsidiary of the Company, has entered into an Exclusive License Agreement with Visus Therapeutics, Inc. U.S.A.